Neuren Pharmaceuticals
Dec 13, 2019
Fragile X Syndrome Market
AI-driven treatment approach and growing Fragile X Syndrome market size Healx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and invest in R&D related to rare neurological disorders. Under the deal signed, Healx Artificial Intelligence (AI) drug discovery platfo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
